Risk of cardiac valve regurgitation with dopamine agonist use in Parkinson's disease and hyperprolactinaemia: a multi-country, nested case-control study.
Trifirò G, Mokhles MM, Dieleman JP, van Soest EM, Verhamme K, Mazzaglia G, Herings R, de Luise C, Ross D, Brusselle G, Colao A, Haverkamp W, Schade R, van Camp G, Zanettini R, Sturkenboom MC.
Trifirò G, et al. Among authors: van soest em, van camp g.
Drug Saf. 2012 Feb 1;35(2):159-71. doi: 10.2165/11594940-000000000-00000.
Drug Saf. 2012.
PMID: 22204718